Written answers
Tuesday, 17 December 2019
Department of Health
Medicinal Products
Alan Kelly (Tipperary, Labour)
Link to this: Individually | In context | Oireachtas source
354. To ask the Minister for Health the way in which the gainshare and incentive model for biosimilar prescribing operates; if €500 per patient is being allocated to hospital treatment areas that prescribe biosimilars is taking place as reported; if the HSE or his Department has estimated the overall savings potential of biosimilar prescribing; and if he will make a statement on the matter. [52711/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The Health Service Executive has operational responsibility for best-value biological medicines, thus the matter has been referred to the HSE for its attention and direct reply to the Deputy.
No comments